Human African Trypanosomiasis (Sleeping Sickness)—Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention

被引:0
|
作者
Yeimer Ortiz-Martínez
Menan Gérard Kouamé
Felix Bongomin
Sulaiman Lakoh
Andrés F. Henao-Martínez
机构
[1] Universidad Industrial de Santander,Department of Internal Medicine
[2] CHU de Treichville,Programme PAC
[3] Gulu University,CI
[4] University of Sierra Leone,Department of Medical Microbiology and Immunology, Faculty of Medicine
[5] University of Colorado,College of Medicine and Allied Health Sciences
[6] Anschutz Medical Campus,Division of Infectious Diseases, Department of Medicine
来源
Current Tropical Medicine Reports | 2023年 / 10卷
关键词
Human African trypanosomiasis (HAT); Sleeping sickness; Neglected tropical disease (NTD); NTD elimination goals;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:222 / 234
页数:12
相关论文
共 50 条
  • [21] Treatment options for second-stage gambiense human African trypanosomiasis
    Eperon, Gilles
    Balasegaram, Manica
    Potet, Julien
    Mowbray, Charles
    Valverde, Olaf
    Chappuis, Francois
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (11) : 1407 - 1417
  • [22] Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis
    Jones, Amy J.
    Kaiser, Marcel
    Avery, Vicky M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1859 - 1861
  • [23] New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice
    Lindner, Andreas K.
    Lejon, Veerle
    Chappuis, Francois
    Seixas, Jorge
    Kazumba, Leon
    Barrett, Michael P.
    Mwamba, Erick
    Erphas, Olema
    Akl, Elie A.
    Villanueva, Gemma
    Bergman, Hanna
    Simarro, Pere
    Ebeja, Augustin Kadima
    Priotto, Gerardo
    Franco, Jose Ramon
    LANCET INFECTIOUS DISEASES, 2020, 20 (02): : E38 - E46
  • [24] Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis
    Blum, J
    Nkunku, S
    Burri, C
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (05) : 390 - 400
  • [25] Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children
    Eperon, Gilles
    Schmid, Caecilia
    Loutan, Louis
    Chappuis, Francois
    ACTA TROPICA, 2007, 101 (01) : 31 - 39
  • [26] Polysomnography as a diagnosis and post-treatment follow-up tool in human African trypanosomiasis: A case study in an infant
    Mpandzou, Ghislain
    Cespuglio, Raymond
    Ngampo, Stephane
    Bandzouzi, Bebene
    Bouteille, Bernard
    Vincendeau, Philippe
    Buguet, Alain
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 305 (1-2) : 112 - 115
  • [27] Oral fexinidazole for gambiense human African trypanosomiasis: significant changes for clinical practice
    Lindner, Andreas K.
    Stich, August
    FLUGMEDIZIN TROPENMEDIZIN REISEMEDIZIN, 2020, 27 (01): : 26 - 31
  • [28] The Changing Epidemiology of Human African Trypanosomiasis among Patients from Nonendemic Countries-1902-2012
    Neuberger, Ami
    Meltzer, Eyal
    Leshem, Eyal
    Dickstein, Yaakov
    Stienlauf, Shmuel
    Schwartz, Eli
    PLOS ONE, 2014, 9 (02):
  • [29] Actigraphy in Human African Trypanosomiasis as a Tool for Objective Clinical Evaluation and Monitoring: A Pilot Study
    Njamnshi, Alfred K.
    Etet, Paul F. Seke
    Perrig, Stephen
    Acho, Alphonse
    Funsah, Julius Y.
    Mumba, Dieudonne
    Muyembe, Jean-Jacques
    Kristensson, Krister
    Bentivoglio, Marina
    PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (02):
  • [30] The treatment pathways followed by cases of human African trypanosomiasis in western Kenya and eastern Uganda
    Bukachi, S. A.
    Wandibba, S.
    Nyamongo, I. K.
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2009, 103 (03): : 211 - 220